Stockscreener 앱 받기
1.20
2.44%
-0.03
시간 외 거래:
1.76
0.56
+46.67%
Biocardia Inc 주식(BCDA)의 최신 뉴스
BioCardia, Inc. to Host Conference Call for 2025 Financial Results and Corporate Update on March 24, 2026 - Quiver Quantitative
BioCardia to Host 2025 Financial Results and Corporate Update Conference Call on March 24, 2026 - Yahoo Finance Singapore
Quarterly Risk: Does BioCardia Inc stock have upside surprise potential2026 Technical Overview & Expert Approved Trade Ideas - baoquankhu1.vn
FDA accepts BioCardia pre-submission for Helix catheter By Investing.com - Investing.com South Africa
BioCardia Inc Announces Pre-Submission Approval Package for Helix Transendocardial Delivery Catheter Accepted by FDA - marketscreener.com
BioCardia Announces FDA Review of Helix Transendocardial Delivery Catheter Pre-Submission Package – Key 2026 Regulatory Milestones - Minichart
FDA accepts BioCardia pre-submission for Helix catheter - Investing.com
BioCardia (BCDA) Advances Heart Catheter Approval with FDA Submi - GuruFocus
BioCardia Advances Helix Catheter Toward FDA Marketing Clearance - TipRanks
BioCardia Announces Pre-Submission Approval Package For Helix Transendocardial Delivery Catheter Accepted By FDA - TradingView
BioCardia Announces Pre-Submission Approval Package for Helix Transendocardial Delivery Catheter Accepted by FDA - The Manila Times
BioCardia® Announces FDA Acceptance of Pre-Submission Package for Helix Transendocardial Delivery Catheter - Quiver Quantitative
FDA accepts BioCardia (NASDAQ: BCDA) Helix catheter pre-submission for review - Stock Titan
FDA to review new heart catheter for cell and gene therapy delivery - Stock Titan
Chart Watch: Is now the right time to enter BioCardia IncDay Trade & AI Enhanced Market Trend Forecasts - baoquankhu1.vn
BCDA Stock Price, Quote & Chart | BIOCARDIA INC (NASDAQ:BCDA) - ChartMill
Aug Reactions: Can BioCardia Inc ride the EV wave2026 Performance Recap & Real-Time Stock Entry Alerts - baoquankhu1.vn
Weekly Recap: Is BioCardia Inc a momentum stock2026 Analyst Calls & Risk Managed Investment Entry Signals - baoquankhu1.vn
BioCardia files prospectus for resale of 549K shares; stock down 8.6% - MSN
Market Outlook: Whats the profit margin of BioCardia IncJuly 2025 EndofMonth & Weekly Top Stock Performers List - baoquankhu1.vn
BioCardia Late Breaking Echocardiography Clinical Results from CardiAMP HF Trial Presented at Technology and Heart Failure Therapeutics (THT) - Bitget
BioCardia Highlights Positive CardiAMP Phase III Heart Failure Data - TipRanks
BioCardia reports positive echocardiography results from Phase III CardiAMP HF trial indicating reduced ventricular remodeling - TradingView
New CardiAMP HF echo data from BioCardia (NASDAQ: BCDA) highlight ventricular remodeling - Stock Titan
Heart failure cell therapy shows less adverse cardiac remodeling - Stock Titan
BCDA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
BCDA Should I Buy - Intellectia AI
Loss Report: Can BioCardia Inc ride the EV wavePortfolio Profit Report & Daily Growth Stock Tips - baoquankhu1.vn
BioCardia (NASDAQ:BCDA) Trading Up 3.1% – Here’s Why - Defense World
Chipmakers Recap: Does BioCardia Inc have pricing powerQuarterly Performance Summary & Fast Gaining Stock Reports - baoquankhu1.vn
S P Trends: Can BioCardia Inc. ride the EV waveMarket Trend Review & Verified Short-Term Plans - mfd.ru
BCDA PE Ratio & Valuation, Is BCDA Overvalued - Intellectia AI
How is BioCardia Inc. managing supply chain issuesMarket Volume Summary & Weekly Top Performers Watchlists - mfd.ru
Biocardia's Regulatory Milestone: FDA Submission Paves Way for Cardiac Delivery System () - aktiencheck.de
BioCardia submits FDA pre-submission for heart delivery catheter By Investing.com - Investing.com Nigeria
Biocardia files pre-submission for FDA approval of Helix(TM) - marketscreener.com
BioCardia (BCDA) Advances Helix Catheter Approval with FDA Pre-S - GuruFocus
BioCardia submits FDA pre-submission for heart delivery catheter - Investing.com
BioCardia Advances FDA Pathway for Helix Delivery Catheter - TipRanks
BioCardia Submits Pre-Submission to FDA for Helix Transendocardial Delivery Catheter Approval - Quiver Quantitative
BioCardia Files Pre-Submission for FDA Approval of Helix™ Transendocardial Delivery Catheter for Therapeutic and Diagnostic Agent Delivery to the Heart - marketscreener.com
BioCardia Files Pre-Submission for FDA Approval of Helix™ - GlobeNewswire
Insider Buying: Peter Altman Acquires Additional Shares of BioCa - GuruFocus
BioCardia’s CardiAMP Heart Failure Data Selected for LBCT - TipRanks
BioCardia Announces Late Breaking Echocardiography Results from the CardiAMP HF Trial to be Presented at Technology and Heart Failure Therapeutics (THT) - The Manila Times
BioCardia, Inc. Announces Presentation of CardiAMP HF Trial Data - TradingView
Heart failure cell therapy trial lands late-breaking THT slot for echo data - stocktitan.net
Insider Sell: Will Matador Resources Company benefit from geopolitical trendsDividend Hike & Weekly Momentum Stock Picks - baoquankhu1.vn
Activity Recap: Does BioCardia Inc have consistent dividend growthQuarterly Trade Review & Growth Oriented Trade Recommendations - baoquankhu1.vn
Aug Ideas: Whats Sono Tek Corporations historical returnPortfolio Value Report & Risk Controlled Swing Trade Alerts - baoquankhu1.vn
Chipmakers Recap: Should you avoid BioCardia Inc stock right now2025 Earnings Impact & Safe Swing Trade Setup Alerts - baoquankhu1.vn
IO Biotech (IOBT) Explores Strategic Alternatives, Stock Surges 19.36% - Intellectia AI
Altman Peter buys BioCardia (BCDA) shares worth $1,194 By Investing.com - Investing.com Nigeria
Altman Peter buys BioCardia (BCDA) shares worth $1,194 - Investing.com
Trend Review: Is BioCardia Inc. in a long term uptrendWeekly Investment Summary & Weekly Top Gainers Alerts - baoquankhu1.vn
US Stocks Recap: Can BioCardia Inc expand its profit marginsJuly 2025 Big Picture & Weekly Chart Analysis and Guides - baoquankhu1.vn
Swing Trade: Is BioCardia Inc stock forming a triangle patternGap Up & High Accuracy Trade Alerts - baoquankhu1.vn
Can BioCardia Inc. stock deliver surprise earnings beat2025 Buyback Activity & AI Enhanced Trade Execution Alerts - Bộ Nội Vụ
Published on: 2026-01-10 18:46:33 - Улправда
Will BioCardia Inc. (6JU0) stock keep high P E multiplesPortfolio Return Report & Reliable Entry Point Alerts - Улправда
Can BioCardia Inc. stock continue upward trendWeekly Stock Report & AI Optimized Trading Strategy Guides - Улправда
Forecast Cut: Will BioCardia Inc. stock rally after Fed decisionsJuly 2025 Weekly Recap & Daily Entry Point Alerts - ulpravda.ru
Will BioCardia Inc. stock rally after Fed decisionsMarket Activity Report & Community Trade Idea Sharing Platform - Улправда
How BioCardia Inc. stock reacts to bond yields2026 world cup usa national team qualification midfield engines set piece tactics expert forecast analysis - Улправда
Bull Run: Why analysts raise outlook for BioCardia Inc 6JU0 stock2025 Market Outlook & Daily Profit Focused Stock Screening - moha.gov.vn
Profit Review: Will BioCardia Inc 6JU0 stock sustain uptrend momentumJuly 2025 Volume & Safe Capital Growth Stock Tips - moha.gov.vn
1.20%
0.06%
자본화:
|
볼륨(24시간):